Zobrazeno 1 - 10 of 724 pro vyhledávání: '"MacKean M"'
3
Akademický článek
Validation of the Scottish Inflammatory Prognostic Score (SIPS) in NSCLC Patients Treated with First-Line Pembrolizumab.
Autor: Gomez-Randulfe I; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Gomes F; The Christie NHS Foundation Trust, Manchester M20 4BX, UK., MacKean M; Edinburgh Cancer Centre, NHS Lothian, Edinburgh EH4 2XU, UK., Phillips I; Edinburgh Cancer Centre, NHS Lothian, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre (Edinburgh), University of Edinburgh, Edinburgh EH4 2XR, UK., Stares M; Edinburgh Cancer Centre, NHS Lothian, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre (Edinburgh), University of Edinburgh, Edinburgh EH4 2XR, UK.
Publikováno v: Cancers [Cancers (Basel)] 2024 Nov 14; Vol. 16 (22). Date of Electronic Publication: 2024 Nov 14.
Zobrazit plný text záznamu
4
Editorial & Opinion
Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer.
Autor: Phillips I; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland. Electronic address: iain.phillips@nhslothian.scot.nhs.uk., Walton A; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland; St Johns Hospital, Livingston, West Lothian, Scotland., Barrie C; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland; St Johns Hospital, Livingston, West Lothian, Scotland., Mackean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland.
Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Jul; Vol. 36 (7), pp. e242-e243. Date of Electronic Publication: 2024 Mar 18.
Zobrazit plný text záznamu
5
Akademický článek
Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer.
Autor: Phillips I; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK iain.phillips@nhslothian.scot.nhs.uk.; Edinburgh University, Edinburgh, UK., Deans M; Cancer Information Team, Western General Hospital, Edinburgh, UK., Walton A; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK.; St Johns Hospital, Livingston, UK., Vallet M; Edinburgh University, Edinburgh, UK., Mencnarowksi J; St Johns Hospital, Livingston, UK., McMillan D; St Johns Hospital, Livingston, UK., Peacock C; St Johns Hospital, Livingston, UK., Hall P; Edinburgh University, Edinburgh, UK., O'Brien F; St Johns Hospital, Livingston, UK., Stares M; Edinburgh University, Edinburgh, UK., Mackean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK., Plant T; St Johns Hospital, Livingston, UK., Grecian R; St Johns Hospital, Livingston, UK., Allan L; Department of Nutrition and Dietetics, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Petrie R; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK., Blues D; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK., Haddad S; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK., Barrie C; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, UK.; St Johns Hospital, Livingston, UK.
Publikováno v: BMJ supportive & palliative care [BMJ Support Palliat Care] 2024 Apr 17. Date of Electronic Publication: 2024 Apr 17.
Zobrazit plný text záznamu
6
Akademický článek
Factors predicting long-term weight maintenance in anorexia nervosa: a systematic review.
Autor: Maurel L; Schoen Clinic Chelsea, London, UK., MacKean M; Schoen Clinic Chelsea, London, UK., Lacey JH; Schoen, Birmingham, UK. hlacey@sgul.ac.uk.; St George's, University of London, London, UK. hlacey@sgul.ac.uk.
Publikováno v: Eating and weight disorders : EWD [Eat Weight Disord] 2024 Apr 06; Vol. 29 (1), pp. 24. Date of Electronic Publication: 2024 Apr 06.
Zobrazit plný text záznamu
8
Akademický článek
Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab.
Autor: Stares M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK. Electronic address: mark.stares@ed.ac.uk., Doyle E; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Chapple S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Raynes G; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., MacDonald J; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Barrie C; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Laird B; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK., MacKean M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Philips I; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK.
Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Mar; Vol. 189, pp. 107497. Date of Electronic Publication: 2024 Jan 29.
Zobrazit plný text záznamu
9
Akademický článek
Early prehabilitation in suspected locally advanced and metastatic lung cancer.
Autor: Phillips I; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK iain.phillips@nhslothian.scot.nhs.uk., Petrie R; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Allan L; Department of Nutrition and Dietetics, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK., Hall P; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Walton A; Oncology department, St Johns Hospital, Livingston, UK., McMillan D; Oncology department, St Johns Hospital, Livingston, UK., Peacock C; Oncology department, St Johns Hospital, Livingston, UK., Primrose L; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Vallet M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Mencnarowksi J; Oncology department, St Johns Hospital, Livingston, UK., MacDonald N; Merck Sharp & Dohme UK Ltd, London, UK., Mackean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Barrie C; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.; Oncology department, St Johns Hospital, Livingston, UK.
Publikováno v: BMJ supportive & palliative care [BMJ Support Palliat Care] 2024 Jan 08; Vol. 13 (e3), pp. e908-e911. Date of Electronic Publication: 2024 Jan 08.
Zobrazit plný text záznamu
10
Akademický článek
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.
Autor: Raynes G; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Stares M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK., Low S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Haron D; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Sarwar H; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Abhi D; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Barrie C; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK., Laird B; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK., Caledonian Cachexia Collaborative, Phillips I; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.; Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK., MacKean M; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.
Publikováno v: Cancers [Cancers (Basel)] 2023 Nov 21; Vol. 15 (23). Date of Electronic Publication: 2023 Nov 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje